OMEGA THERAPEUTICS INC (OMGA)       5.34  +0.32 (+6.37%)

5.34  +0.32 (+6.37%)

US68217N1054 - Common Stock

OMEGA THERAPEUTICS INC5.34

NASDAQ:OMGA (10/4/2022, 11:20:06 AM)+0.32 (+6.37%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 08-04 2022-08-04/bmo Earnings (Next) N/A N/A
Ins Owners 1.88% Inst Owners 88.74%
Market Cap 255.54M Shares 47.85M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 84
IPO 07-30 2021-07-30

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

OMGA Daily chart

Company Profile

Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 79 full-time employees. The company went IPO on 2021-07-30. The firm is engaged in a systematic approach to use mRNA therapeutics as programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programming platform. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth, and differentiation to cell death. The company has deciphered the three-dimensional architecture of the human genome and its accompanying regulators, which are organized into distinct and evolutionarily conserved structures called Insulated Genomic Domains (IGDs). The OMEGA platform enables to systematically identify and validate thousands of DNA-sequence-based epigenomic zip codes within IGDs. Its pipeline consists of early-stage, preclinical programs that span regenerative medicine, multigenic diseases including immunology, oncology, and select monogenic diseases.

Company Info

OMEGA THERAPEUTICS INC

20 Acorn Park Drive

Cambridge MASSACHUSETTS

P: 16179494360.0

CEO: Mahesh Karande

Employees: 79

Website: https://omegatherapeutics.com/

OMGA News

News Image8 days ago - Omega TherapeuticsOmega Therapeutics to Participate in Two Upcoming Investor Conferences

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

News Imagea month ago - Omega TherapeuticsOmega Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

/PRNewswire/ -- Omega Therapeutics, Inc. (NASDAQ: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

News Imagea month ago - Omega TherapeuticsOmega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to using...

News Image2 months ago - Omega TherapeuticsOmega Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress

FDA Clearance of IND Application for OTX-2002, the First Ever Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma Received Launch of Phase 1/2...

News Image2 months ago - Omega TherapeuticsOmega Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Conference

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

News Image3 months ago - Market News VideoWednesday Sector Leaders: Paper & Forest Products, Biotechnology Stocks

OMGA Twits

Here you can normally see the latest stock twits on OMGA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example